Inactive Instrument
IR Biosciences Holdings, Inc. Stock
Stocks
IRBS
US46264M3034
Biotechnology & Medical Research
OTC Markets Traded| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2003-06-30 | |
John N. Fermanis
DFI | Director of Finance/CFO | 72 | 2004-11-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 17 | |
| +0.11% | +2.71% | +0.33% | +28.59% | 46.18B | |
| -1.10% | +1.61% | +39.84% | +27.05% | 44.35B | |
| -3.77% | -6.60% | +320.90% | +515.36% | 42.21B | |
| -1.04% | +1.08% | +2.15% | +67.66% | 40.19B | |
| -0.50% | -0.77% | +11.86% | +40.41% | 29.83B | |
| -0.60% | +4.18% | +21.94% | +124.12% | 17.17B | |
| -0.44% | -9.28% | - | - | 15.7B | |
| -0.57% | +8.12% | +22.15% | +38.93% | 15.32B | |
| -2.83% | -2.81% | -8.29% | -37.43% | 13.09B | |
| Average | -1.07% | +1.67% | +51.36% | +100.59% | 29.34B | |
| Weighted average by Cap. | -1.21% | +1.63% | +65.94% | +122.56% |
Employees
4
